Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Assist Prof Dr Maryam Tabarzad, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iran

Based on Dr. Maryam Tabarzad’s profile, she appears to be a strong candidate for the Best Researcher Award due to several key factors:

Publication profile

google scholar

Educational Background

  • MSc in E-learning in Medical Education (2023): Focused on enhancing lab skills through augmented reality in pharmacy students.
  • PhD in Pharmaceutical Biotechnology (2014): Specialized in DNA aptamers against Coagulation Factor VIII.
  • Pharm.D. (2007): Conducted research on bis(4-nitroaryl-1,4-Dihydropyridine) with pharmacological evaluations.

Professional Experience

  • Assistant Professor: Protein Technology Research Center, Shahid Beheshti University of Medical Science (2014-present).
  • Vice-Chancellor of Research Affairs: Protein Technology Research Center (2018-present).
  • Editorial Roles: Managing Editor for Trends in Peptide and Protein Sciences, Associate Editor for Iranian Journal of Pharmaceutical Research, and Editorial member for Future Natural Products.

Notable Publications

  1. Fathi et al. (2024): Investigated antimicrobial peptides for wound healing, published in Burns (Q2, IF: 3.2).
  2. Fathi et al. (2024): Explored structural features of antimicrobial peptides in Bioorganic Chemistry (Q1, IF: 5.1).
  3. Yazdanicherati et al. (2024): Studied the effect of antimicrobial peptides on gold nanoparticles, published in Modares Journal of Biotechnology.

Teaching Experience

  • Extensive teaching roles in pharmaceutical and medical biotechnology across various institutions, including University of Science and Culture, Gilan University of Medical Sciences, and Shahid Beheshti University of Medical Sciences.

Thesis Supervision

  • Supervised multiple Ph.D. and MSc theses in areas such as biosensors, peptide-nanomolecule interactions, and cancer research.

Conclusion

Dr. Maryam Tabarzad’s impressive academic credentials, significant contributions to pharmaceutical biotechnology, influential editorial roles, and robust teaching and supervisory experience make her a highly suitable candidate for the Best Researcher Award. Her research, particularly in the design and development of antimicrobial peptides and aptamers, along with her leadership in research and education, underscores her excellence in the field.

Publication top notes

Therapeutic applications of nucleic acid aptamers in microbial infections

Aptamers as smart ligands for nano-carriers targeting

Anti-inflammatory activity of bioactive compounds from microalgae and cyanobacteria by focusing on the mechanisms of action

Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication

Silymarin antiproliferative and apoptotic effects: insights into its clinical impact in various types of cancer

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers

Anti-cancer drug delivery using carbohydrate-based polymers

Trends in the design and development of specific aptamers against peptides and proteins

Peptide dendrimers as valuable biomaterials in medical sciences

Baijayantimala Swain | Pharmaceutical Medicinal Chemistry Award | Best Researcher Award

Posted on by ScienceFather

Dr. Baijayantimala Swain | Pharmaceutical Medicinal Chemistry Award | Best Researcher Award

Dr. Baijayantimala Swain, bharat institute of technology- pharmacy, India

Dr. Baijayantimala Swain is an accomplished medicinal chemist with expertise in drug design and discovery, specializing in carbonic anhydrase inhibitors. With a Ph.D. from NIPER Hyderabad, she has synthesized novel compounds targeting various isoforms of carbonic anhydrase, crucial in diseases like cancer and glaucoma. šŸ§Ŗ Her research has led to the development of potent molecules with therapeutic potential. Dr. Swain’s multidisciplinary skills encompass organic synthesis, analytical techniques, and computational chemistry. She is recognized for her contributions to scientific literature and holds a strong academic background, fostering collaborative research in pharmaceutical sciences. šŸŽ“

 

Publication Profile

Scopus

Academic QualificationĀ 

Dr. Baijayantimala Swain forged her path in pharmaceutical sciences. From her Bachelor’s in Pharmaceutical Sciences at Sri Jaydev College in Odisha, India šŸŽ“, she ventured into deeper realms with a Master’s in Medicinal Chemistry at NIPER, Hyderabad, delving into the intricacies of peptide synthesis for anticancer endeavors. Driven by an insatiable thirst for knowledge, she pursued a Ph.D. in Medicinal Chemistry at the same institute, where she honed her skills in designing novel inhibitors for carbonic anhydrases, under the guidance of esteemed mentors. Each milestone illuminated her academic odyssey, shaping her into a versatile researcher.

 

Research Focus šŸ§Ŗ

Dr. Baijayantimala Swain’s research primarily revolves around the design and synthesis of novel compounds targeting carbonic anhydrases, key enzymes involved in various physiological processes. Her work spans the development of diverse chemical entities, including sulfonamide and non-sulfonamide derivatives, ureidosulfocoumarin derivatives, and indole-based hybrids. These compounds hold promise as potential inhibitors of specific isoforms of carbonic anhydrases, with implications for therapeutic intervention in conditions such as cancer and other diseases. Through innovative approaches and meticulous experimentation, Dr. Swain contributes to the advancement of medicinal chemistry, striving to unlock new avenues for drug discovery and development.

 

Publication Top NotesĀ 
  1. “Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors” (2024)
  2. “Design, Synthesis and Biological Assessment of Rhodanine-Linked Benzenesulfonamide Derivatives as Selective and Potent Human Carbonic Anhydrase Inhibitors” (2022) – cited by 1
  3. “Synthesis of a new series of quinoline/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors” (2022) – cited by 7
  4. “Efficient One-pot Synthesis of 3,3-di(indolyl)indolin-2-ones from Isatin and Indole Catalyzed by VOSO4 as Non-Sulfonamide Carbonic Anhydrase Inhibitors” (2022) – cited by 1
  5. “Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases” (2022) – cited by 6
  6. “Design and development of novel series of indole-3-sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors” (2022) – cited by 5
  7. “Design and synthesis of benzenesulfonamide-linked imidazo[2,1-b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors” (2021) – cited by 6